First Financial Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Hold
6,470
0.11% 109
2026
Q1
$238K Hold
6,470
0.09% 116
2025
Q4
$329K Hold
6,470
0.12% 105
2025
Q3
$359K Hold
6,470
0.14% 98
2025
Q2
$447K Hold
6,470
0.2% 78
2025
Q1
$449K Hold
6,470
0.22% 77
2024
Q4
$557K Hold
6,470
0.26% 70
2024
Q3
$770K Sell
6,470
-80
-1% -$10.7K 0.37% 62
2024
Q2
$935K Hold
6,550
0.48% 49
2024
Q1
$841K Hold
6,550
0.43% 56
2023
Q4
$678K Buy
6,550
+118
+2% +$11.7K 0.34% 63
2023
Q3
$585K Buy
+6,432
New +$567K 0.34% 59
2023
Q2
Sell
-10
Closed -$795 362
2023
Q1
$795 Hold
10
﹤0.01% 356
2022
Q4
$676 Hold
10
﹤0.01% 359
2022
Q3
$0 Buy
+10
New +$536 ﹤0.01% 371

Other funds holding NVO

First Financial Corp's NVO Position: Q2 2026 in Review

First Financial Corp held its Novo Nordisk (NVO) position steady in Q2 2026 at 6,470 shares worth $310K. The position accounts for 0.11% of the portfolio, ranked #109.

First Financial Corp first reported a position in NVO in Q3 2022 and has held it in 15 quarters since. The position peaked at $935K in Q2 2024. 343 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • First Financial Corp held 6,470 shares of Novo Nordisk worth $310K as of Q2 2026.
  • First Financial Corp left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.11% of First Financial Corp's portfolio in Q2 2026, its #109 holding.
  • First Financial Corp first reported a position in Novo Nordisk in Q3 2022 and has held it in 15 quarters since.
  • First Financial Corp's Novo Nordisk position peaked at $935K in Q2 2024.
  • 343 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on First Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.